Cargando…
Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer
Castrate-resistant prostate cancer (CRPC) progression is a complex process by which prostate cells acquire the ability to survive and proliferate in the absence or under very low levels of androgens. Most CRPC tumors continue to express the androgen receptor (AR) as well as androgen-responsive genes...
Autores principales: | Zardan, A, Nip, K M, Thaper, D, Toren, P, Vahid, S, Beraldi, E, Fazli, L, Lamoureux, F, Gust, K M, Cox, M E, Bishop, J L, Zoubeidi, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189960/ https://www.ncbi.nlm.nih.gov/pubmed/25133482 http://dx.doi.org/10.1038/oncsis.2014.30 |
Ejemplares similares
-
Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer
por: Shiota, Masaki, et al.
Publicado: (2015) -
Functions of the Lyn tyrosine kinase in health and disease
por: Ingley, Evan
Publicado: (2012) -
Sustained Activation of Lyn Tyrosine Kinase In Vivo Leads to Autoimmunity
por: Hibbs, Margaret L., et al.
Publicado: (2002) -
Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer
por: Vahid, Sepideh, et al.
Publicado: (2016) -
The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer
por: Bishop, Jennifer L., et al.
Publicado: (2014)